When CMI/Compas asked whether consumers felt it was appropriate for the pharmaceutical industry to continue to provide branded and sponsored information and advertising related to their products during the COVID-19 pandemic, 74% agreed that it was OK, and of those, 36% highly agreed.
The findings from CMI/Compas were fielded April …